18 related articles for article (PubMed ID: 3102260)
1. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.
Feuerstein TJ; Hedler L; Jackisch R; Hertting G
Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882
[TBL] [Abstract][Full Text] [Related]
2. 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin.
Rosenberg PA; Loring R; Xie Y; Zaleskas V; Aizenman E
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4865-9. PubMed ID: 1675790
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
Chang GD; Ramirez VD
Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
[TBL] [Abstract][Full Text] [Related]
6. The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Bradbury AJ; Costall B; Domeney AM; Jenner PJ; Marsden CD; Naylor RJ
Neurosci Lett; 1986 Jun; 67(2):208-12. PubMed ID: 2425303
[TBL] [Abstract][Full Text] [Related]
7. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
8. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
[TBL] [Abstract][Full Text] [Related]
9. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
